Epinephrine-Induced and Antiapoptotic Signaling in Prostate Cancer
Abstract
We hypothesize that epinephrine released after emotional stress activates anti-apoptotic signaling pathways in prostate tumors, and contributes to the resistance of advanced prostate cancer to therapies. To test this hypothesis, we propose to examine if stress/epinephrine induces the activation of PKA and BAD phosphorylation in prostate tumors; and determine if stress/epinephrine reduces therapeutic efficacy of anti-cancer treatments. We have developed methodologies to test the role of beta2-AR in stress-induced activation of PKA. PKA activity could be judged by phosphorylation of CREB and BAD. Although BAD phosphorylation is more relevant to antiapoptotic effect of epinephrine, CREB could be used as biomarker of PKA activation. Still, additional experiments are needed to reliably monitor activation of PKA and BAD phosphorylation in xenograft tumors in vivo. Since C42 cells are PTEN deficient, PI3K/Akt pathway is constitutively active and BAD is constitutively phosphorylated in these cells. Thus, to determine whether BAD could be phosphorylated by stress/epinephrine in vivo we need to inhibit PI3K in C42 xenografts. To accomplish this two approaches are under way: first, to use new PI3K inhibitor ZSTK474, second to generate cells that inducibly express PTEN phosphatase.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2009
- Accession Number
- ADA512032
Entities
People
- George Kulik
Organizations
- Wake Forest University